Onconetix, Inc. (ONCO): debt financing — Onconetix issues $117.6K in promissory notes; amends Veru note to $5.2M, extended to Sept 19

Onconetix, Inc.

Issued $58,823.53 principal note to Keystone Capital and $58,823.53 to KCP Fund I, each with $8,823.53 OID, netting $100K total.
Both notes due upon earlier of ELOC proceeds or May 28, 2026, subordinate to existing Veru debt.
Amended Veru note: principal increased by $100K to $5.2M; maturity extended to September 19, 2025.
Veru waived April Veru Note maturity to September 19, 2025 under August 28 waiver agreement.
Notes require mandatory prepayment from subsequent equity offerings (excluding senior lender and Series C preferred proceeds).

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Onconetix, Inc. incurred loan of principal amount of $58,823.53 with KCP Fund I, LLC maturing upon the earlier of (i) the Company's receipt of sufficient proceeds from its equity line of credit with Keystone ... and (ii) May 28, 2026.

Instrument: loan
Principal: principal amount of $58,823.53
Counterparty: KCP Fund I, LLC
Maturity: upon the earlier of (i) the Company's receipt of sufficient proceeds from its equity line of credit with Keystone ... and (ii) May 28, 2026
Event: incurrence

Exact text from the filing

(ii) KCP Fund I, LLC, an affiliate of Keystone (the “ KCP Note ”, and together with the Keystone Note, the “ Notes ”) each with original issue discount of $8,823.53 and a principal amount of $58,823.53

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Onconetix, Inc. incurred loan of principal amount of $58,823.53 with Keystone Capital Partners, LLC maturing upon the earlier of (i) the Company's receipt of sufficient proceeds from its equity line of credit with Keystone ... and (ii) May 28, 2026.

Instrument: loan
Principal: principal amount of $58,823.53
Counterparty: Keystone Capital Partners, LLC
Maturity: upon the earlier of (i) the Company's receipt of sufficient proceeds from its equity line of credit with Keystone ... and (ii) May 28, 2026
Event: incurrence

Exact text from the filing

I, LLC, an affiliate of Keystone (the “ KCP Note ”, and together with the Keystone Note, the “ Notes ”) each with original issue discount of $8,823.53 and a principal amount of $58,823.53. The Notes are due and payable upon the earlier of (i) the Company’s receipt of sufficient proceeds from its equity line of credit with Keystone (the “ ELOC ”) and (ii) May 28,

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Onconetix, Inc. amended loan of aggregate principal amount of $5.2 million with Veru Inc. maturing September 19, 2025.

Instrument: loan
Principal: aggregate principal amount of $5.2 million
Counterparty: Veru Inc.
Maturity: September 19, 2025
Event: amendment

Exact text from the filing

On August 28, 2025, Veru and the Company agreed to amend and restate the September Veru Note (as amended and restated, the “ Second A&R September Veru Note ”). Pursuant to the Second A&R September Veru Note, the principal amount owed to Veru was increased by $100,000 to an aggregate principal amount of $5.2 million, and the maturity date was amended to September 19, 2025.

View on SEC.gov

100 debt financings filed in the last 30 days. Browse all debt financings →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-084500

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.